BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32851577)

  • 1. Clinical and Immunological Characterization of Combined Immunodeficiency Due to TFRC Mutation in Eight Patients.
    Aljohani AH; Al-Mousa H; Arnaout R; Al-Dhekri H; Mohammed R; Alsum Z; Nicolas-Jilwan M; Alrogi F; Al-Muhsen S; Alazami AM; Al-Saud B
    J Clin Immunol; 2020 Nov; 40(8):1103-1110. PubMed ID: 32851577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency.
    Jabara HH; Boyden SE; Chou J; Ramesh N; Massaad MJ; Benson H; Bainter W; Fraulino D; Rahimov F; Sieff C; Liu ZJ; Alshemmari SH; Al-Ramadi BK; Al-Dhekri H; Arnaout R; Abu-Shukair M; Vatsayan A; Silver E; Ahuja S; Davies EG; Sola-Visner M; Ohsumi TK; Andrews NC; Notarangelo LD; Fleming MD; Al-Herz W; Kunkel LM; Geha RS
    Nat Genet; 2016 Jan; 48(1):74-8. PubMed ID: 26642240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic Stem Cell Transplantation Is a Curative Therapy for Transferrin Receptor 1 (TFRC) Deficiency.
    Whangbo JS; Chou J; Al-Dhekri H; Harris M; Geha RS; Pai SY; Al-Herz W
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):753-759.e2. PubMed ID: 33096268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Homozygous Germline Mutation in Transferrin Receptor 1 (TfR1) Leads to Combined Immunodeficiency and Provides New Insights into Iron-Immunity Axis.
    Aba Ü; Maslak İC; İpşir C; Pehlivan D; Warnock NI; Tumes DJ; Cildir G; Erman B
    J Clin Immunol; 2024 Jan; 44(2):55. PubMed ID: 38270687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in
    Klemann C; Camacho-Ordonez N; Yang L; Eskandarian Z; Rojas-Restrepo JL; Frede N; Bulashevska A; Heeg M; Al-Ddafari MS; Premm J; Seidl M; Ammann S; Sherkat R; Radhakrishnan N; Warnatz K; Unger S; Kobbe R; Hüfner A; Leahy TR; Ip W; Burns SO; Fliegauf M; Grimbacher B
    Front Immunol; 2019; 10():297. PubMed ID: 30941118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients.
    Al-Saud BK; Al-Sum Z; Alassiri H; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Arnaout R; Alsmadi O; Borrero E; Abu-Staiteh A; Rawas F; Al-Mousa H; Hawwari A
    J Clin Immunol; 2013 Nov; 33(8):1325-35. PubMed ID: 24122029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel
    Aminorroaya A; Rayzan E; Shahkarami S; Seyedpour S; Zoghi S; Aryan Z; Somekh I; Rohlfs M; Klein C; Esmaeilzadeh H; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):410-415. PubMed ID: 35996251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center.
    Wu J; Zhong W; Yin Y; Zhang H
    BMC Pediatr; 2019 Nov; 19(1):410. PubMed ID: 31684895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
    Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
    [No Abstract]   [Full Text] [Related]  

  • 11. Case Report: A Novel Synonymous ARPC1B Gene Mutation Causes a Syndrome of Combined Immunodeficiency, Asthma, and Allergy With Significant Intrafamilial Clinical Heterogeneity.
    Papadatou I; Marinakis N; Botsa E; Tzanoudaki M; Kanariou M; Orfanou I; Kanaka-Gantenbein C; Traeger-Synodinos J; Spoulou V
    Front Immunol; 2021; 12():634313. PubMed ID: 33679784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
    Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
    Front Immunol; 2020; 11():1948. PubMed ID: 33178177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion Mosaicism in Primary Immunodeficiency Diseases.
    Miyazawa H; Wada T
    Front Immunol; 2021; 12():783022. PubMed ID: 34868061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India.
    Aluri J; Desai M; Gupta M; Dalvi A; Terance A; Rosenzweig SD; Stoddard JL; Niemela JE; Tamankar V; Mhatre S; Bargir U; Kulkarni M; Shah N; Aggarwal A; Lashkari HP; Krishna V; Govindaraj G; Kalra M; Madkaikar M
    Front Immunol; 2019; 10():23. PubMed ID: 30778343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T
    Stepensky P; Keller B; Shamriz O; von Spee-Mayer C; Friedmann D; Shadur B; Unger S; Fuchs S; NaserEddin A; Rumman N; Amro S; Molho Pessach V; Abuzaitoun O; Somech R; Elpeleg O; Ehl S; Warnatz K
    J Clin Immunol; 2018 May; 38(4):527-536. PubMed ID: 29948574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Laboratory, and Molecular Findings for 63 Patients With Severe Combined Immunodeficiency: A Decade´s Experience.
    Fazlollahi MR; Pourpak Z; Hamidieh AA; Movahedi M; Houshmand M; Badalzadeh M; Nourizadeh M; Mahloujirad M; Arshi S; Nabavi M; Gharagozlou M; Khayatzadeh A; Dabbaghzade A; Atarod L; Zandieh F; Sadeghi Shabestary M; Mesdaghi M; Mohammadzadeh I; Mahdaviani SA; Eslamian MH; Pesaran F; Bahraminia E; Abolnezhadian F; Arij Z; Moin M
    J Investig Allergol Clin Immunol; 2017; 27(5):299-304. PubMed ID: 28266921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
    Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
    Front Immunol; 2020; 11():2001. PubMed ID: 33013854
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of
    Conway AJ; Brown FC; Rank G; Kile BT; Morton CJ; Jane SM; Curtis DJ
    Blood Adv; 2018 Aug; 2(15):1914-1922. PubMed ID: 30093529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review.
    Jamee M; Moniri S; Zaki-Dizaji M; Olbrich P; Yazdani R; Jadidi-Niaragh F; Aghamahdi F; Abolhassani H; Condliffe AM; Aghamohammadi A; Azizi G
    Clin Rev Allergy Immunol; 2020 Dec; 59(3):323-333. PubMed ID: 31111319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case with Purine Nucleoside Phosphorylase Deficiency Suffering from Late-Onset Systemic Lupus Erythematosus and Lymphoma.
    Al-Saud B; Al Alawi Z; Hussain FB; Hershfield M; Alkuraya FS; Al-Mayouf SM
    J Clin Immunol; 2020 Aug; 40(6):833-839. PubMed ID: 32514656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.